Understanding how vaccines can reduce antibiotic use for children's respiratory infections
Official title: Quantifying the impact of vaccines on antibiotic use for respiratory infections in children
Funded at University of California Berkeley · NIH-11065421 · Data updated 2026-11-12
This study is looking at how vaccines can help reduce the need for antibiotics in kids with common respiratory infections, and it’s aimed at helping doctors understand how to use vaccines better to keep children healthy and fight antibiotic resistance.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project start | May 1, 2023 |
| Project end | April 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $46,368 |
| NIH project number | 5F31AI174773-03 |
| Project ID | NIH-11065421 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children aged 0-11 years who experience acute respiratory infections.
✕Less likely to help
Patients who do not have acute respiratory infections or are outside the age range of 0-11 years may not benefit from this research.
What this research studies
This research investigates the role of vaccines in decreasing the use of antibiotics for acute respiratory infections (ARIs) in children. It aims to quantify how much antibiotic prescriptions are linked to vaccine-preventable respiratory pathogens like Streptococcus pneumoniae, influenza virus, and respiratory syncytial virus (RSV). By analyzing data on outpatient antibiotic use, the study will evaluate the effectiveness of existing and potential vaccines in reducing unnecessary antibiotic prescriptions. This research is crucial for informing healthcare policies and improving vaccine strategies to combat antibiotic resistance.
Why it matters
Potential benefit: If successful, this research could lead to reduced antibiotic use in children, thereby decreasing the risk of antibiotic resistance and improving overall child health.
How similar studies have gone: Previous research has shown that vaccines can effectively reduce antibiotic use for certain infections, indicating a promising approach in this area.
Where this research is happening
-
University of California Berkeley
Berkeley, United States Active
Researchers
- Principal investigator: King, Laura — University of California Berkeley
- Study coordinator: King, Laura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.